These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37113185)

  • 1. Investigation of treatment satisfaction and health-related quality of life after add-on to metformin-based therapy in patients with type 2 diabetes.
    Chang YW; Shen FC; Chen CY
    Front Public Health; 2023; 11():1152284. PubMed ID: 37113185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translation, revision, and validation of the Chinese version of the Satisfaction with Oral Anti-Diabetic Agent Scale (C-SOADAS) in patients with type 2 diabetes mellitus.
    Lin YJ; Wang CY; Chang EH; Cheng SW; Ko Y
    Patient Prefer Adherence; 2018; 12():667-672. PubMed ID: 29750021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric evaluation of the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS).
    Donatti C; Wild D; Horblyuk R; Beusterien KM; Anderson RT; Arondekar B; Dibenedetti DB
    Diabetes Res Clin Pract; 2008 Apr; 80(1):108-13. PubMed ID: 18207601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Audit of Diabetes-Dependent Quality of Life (ADDQoL) [Chinese Version for Singapore] questionnaire: reliability and validity among Singaporeans with type 2 diabetes mellitus.
    Soon SS; Goh SY; Bee YM; Poon JL; Li SC; Thumboo J; Wee HL
    Appl Health Econ Health Policy; 2010; 8(4):239-49. PubMed ID: 20578779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and other patient-reported outcomes in adult Lebanese patients with type 2 diabetes during COVID-19 pandemic.
    Naous E; Boulos M; Sleilaty G; Achkar AA; Gannagé-Yared MH
    J Endocrinol Invest; 2022 Apr; 45(4):763-772. PubMed ID: 34780052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications.
    Alcubierre N; Rubinat E; Traveset A; Martinez-Alonso M; Hernandez M; Jurjo C; Mauricio D
    Health Qual Life Outcomes; 2014 Aug; 12():131. PubMed ID: 25138117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND).
    Tajima A; Tobe K; Eiki JI; Origasa H; Watada H; Shimomura I; Tokita S; Kadowaki T
    BMJ Open Diabetes Res Care; 2022 Dec; 10(6):. PubMed ID: 36585033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PANORAMA: a European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus--study design.
    Bradley C; de Pablos-Velasco P; Parhofer KG; Eschwège E; Gönder-Frederick L; Simon D
    Prim Care Diabetes; 2011 Dec; 5(4):231-9. PubMed ID: 21752743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective real-world study of dapagliflozin versus other oral antidiabetic drugs added to metformin in patients with type 2 diabetes.
    Huang H; Bell KF; Gani R; Tugwell CW; Eudicone JM; Krukas-Hampel MR
    Am J Manag Care; 2018 Apr; 24(8 Suppl):S132-S137. PubMed ID: 29693359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Reported Satisfaction to Treatment, Quality of Life and General Health of Type 2 Diabetes Patients with Inadequate Glycemic Control from North-Eastern Romania.
    Grigorescu ED; Lăcătușu CM; Crețu I; Floria M; Onofriescu A; Ceasovschih A; Mihai BM; Șorodoc L
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33801100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in type 2 diabetes mellitus patients requiring insulin treatment in Buenos Aires, Argentina: a cross-sectional study.
    Pichon-Riviere A; Irazola V; Beratarrechea A; Alcaraz A; Carrara C
    Int J Health Policy Manag; 2015 Apr; 4(7):475-80. PubMed ID: 26188812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) questionnaire in patients with diabetes in a multi-ethnic Asian country.
    Wee HL; Tan CE; Goh SY; Li SC
    Pharmacoeconomics; 2006; 24(7):673-82. PubMed ID: 16802843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents.
    Vinik AI; Cincotta AH; Scranton RE; Bohannon N; Ezrokhi M; Gaziano JM
    Endocr Pract; 2012; 18(6):931-43. PubMed ID: 23186965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of empagliflozin add-on therapy on quality of life in patients of type 2 diabetes mellitus with hypertension: A prospective study.
    Najar IA; Masoodi SR; Mir SA; Bhat MH; Patyar RR; Patyar S
    Indian J Public Health; 2022 Nov; 66(Supplement):S41-S44. PubMed ID: 36412472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan.
    Yabe D; Higashiyama H; Kadowaki T; Origasa H; Shimomura I; Watada H; Tobe K; Iglay K; Tokita S; Seino Y
    BMJ Open Diabetes Res Care; 2020 Nov; 8(2):. PubMed ID: 33188008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?
    Emami-Riedmaier A; Schaeffeler E; Nies AT; Mörike K; Schwab M
    J Intern Med; 2015 Feb; 277(2):235-247. PubMed ID: 25418285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of diabetes-dependent quality of life (ADDQoL) in women and men in Poland with type 1 and type 2 diabetes.
    Bąk E; Nowak-Kapusta Z; Dobrzyn-Matusiak D; Marcisz-Dyla E; Marcisz C; Krzemińska SA
    Ann Agric Environ Med; 2019 Sep; 26(3):429-438. PubMed ID: 31559799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V).
    Liu J; Jiang X; Xu B; Wang G; Cui N; Zhang X; Liu J; Mu Y; Guo L
    Adv Ther; 2020 Apr; 37(4):1675-1687. PubMed ID: 32130661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study.
    Alvarez Guisasola F; Tofé Povedano S; Krishnarajah G; Lyu R; Mavros P; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():25-32. PubMed ID: 18435671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.